SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 3,500 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 3,500 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -41.7% | 3,500 | -36.4% | 0.00% | – |
| Q1 2022 | $12,000 | -52.0% | 5,500 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | -56.1% | 5,500 | -26.7% | 0.00% | – |
| Q3 2021 | $57,000 | -20.8% | 7,500 | 0.0% | 0.00% | – |
| Q2 2021 | $72,000 | +1.4% | 7,500 | -13.8% | 0.00% | – |
| Q1 2021 | $71,000 | +29.1% | 8,700 | +6.7% | 0.00% | – |
| Q4 2020 | $55,000 | +3.8% | 8,150 | +69.8% | 0.00% | – |
| Q3 2020 | $53,000 | +152.4% | 4,800 | +45.5% | 0.00% | – |
| Q2 2020 | $21,000 | +425.0% | 3,300 | +43.5% | 0.00% | – |
| Q1 2020 | $4,000 | -50.0% | 2,300 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +60.0% | 2,300 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
| B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
| EMFO, LLC | 209,398 | $185,527 | 0.19% |
| Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
| Mayo Clinic | 300,000 | $267,000 | 0.14% |
| swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
| Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
| Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
| EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
| Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |